|Articles|March 1, 2006
- Pharmaceutical Executive-03-01-2006
- Volume 0
- Issue 0
South Africa
Author(s)Frederic Boucheseiche, Kirsten Craze
Sponsored and produced by Focus Reports.
Advertisement
Articles in this issue
about 20 years ago
Global Report: Chemicals Legislation in Europeabout 20 years ago
Pharma's Next Top Model: Slimmer Business Modelsabout 20 years ago
Market Research Roundtableabout 20 years ago
Holding Their Breath: Inhaled Insulinabout 20 years ago
Sales Management: Spending Under Scrutinyabout 20 years ago
Genzyme: The Price of Successabout 20 years ago
Invisible Prescribers: What You Do and Don't Know About NPs and PAsabout 20 years ago
From the Editor: Fine Whinesabout 20 years ago
Legal: Hey, Good Lookin': Sex Discrimination in Hiring Repsabout 20 years ago
Thought Leader: Q&A with Hugo StephensonAdvertisement
Related Content
Advertisement
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5